nodes	percent_of_prediction	percent_of_DWPC	metapath
Caffeine—migraine—Prednisone—Crohn's disease	0.742	1	CpDpCtD
Caffeine—PIK3CB—mouth—Crohn's disease	0.00384	0.0451	CbGeAlD
Caffeine—PIK3CA—mouth—Crohn's disease	0.0038	0.0446	CbGeAlD
Caffeine—ATM—epithelium—Crohn's disease	0.00289	0.0339	CbGeAlD
Caffeine—ATM—skin of body—Crohn's disease	0.00275	0.0322	CbGeAlD
Caffeine—PRKDC—smooth muscle tissue—Crohn's disease	0.00263	0.0309	CbGeAlD
Caffeine—PIK3CD—epithelium—Crohn's disease	0.00256	0.0301	CbGeAlD
Caffeine—PIK3CD—smooth muscle tissue—Crohn's disease	0.00247	0.029	CbGeAlD
Caffeine—PIK3CD—skin of body—Crohn's disease	0.00244	0.0286	CbGeAlD
Caffeine—PRKDC—mammalian vulva—Crohn's disease	0.00237	0.0278	CbGeAlD
Caffeine—PIK3CB—epithelium—Crohn's disease	0.00224	0.0262	CbGeAlD
Caffeine—ATM—lymphoid tissue—Crohn's disease	0.00223	0.0261	CbGeAlD
Caffeine—PIK3CD—mammalian vulva—Crohn's disease	0.00222	0.0261	CbGeAlD
Caffeine—PIK3CA—epithelium—Crohn's disease	0.00221	0.026	CbGeAlD
Caffeine—ATM—digestive system—Crohn's disease	0.0022	0.0258	CbGeAlD
Caffeine—PIK3CB—smooth muscle tissue—Crohn's disease	0.00215	0.0253	CbGeAlD
Caffeine—PIK3CA—smooth muscle tissue—Crohn's disease	0.00213	0.025	CbGeAlD
Caffeine—RYR1—smooth muscle tissue—Crohn's disease	0.00213	0.025	CbGeAlD
Caffeine—PIK3CB—skin of body—Crohn's disease	0.00213	0.0249	CbGeAlD
Caffeine—PIK3CA—skin of body—Crohn's disease	0.0021	0.0247	CbGeAlD
Caffeine—PIK3CD—lymphoid tissue—Crohn's disease	0.00197	0.0232	CbGeAlD
Caffeine—PIK3CD—digestive system—Crohn's disease	0.00195	0.0229	CbGeAlD
Caffeine—PIK3CB—mammalian vulva—Crohn's disease	0.00194	0.0227	CbGeAlD
Caffeine—RYR1—mammalian vulva—Crohn's disease	0.00192	0.0225	CbGeAlD
Caffeine—PIK3CA—mammalian vulva—Crohn's disease	0.00192	0.0225	CbGeAlD
Caffeine—PIK3CB—lymphoid tissue—Crohn's disease	0.00172	0.0202	CbGeAlD
Caffeine—PRKDC—Danazol—Prednisone—Crohn's disease	0.00171	1	CbGdCrCtD
Caffeine—PIK3CA—lymphoid tissue—Crohn's disease	0.0017	0.02	CbGeAlD
Caffeine—PIK3CB—digestive system—Crohn's disease	0.0017	0.02	CbGeAlD
Caffeine—PIK3CA—digestive system—Crohn's disease	0.00168	0.0197	CbGeAlD
Caffeine—ADORA2B—smooth muscle tissue—Crohn's disease	0.00157	0.0184	CbGeAlD
Caffeine—ADORA2B—mammalian vulva—Crohn's disease	0.00141	0.0166	CbGeAlD
Caffeine—ATM—lymph node—Crohn's disease	0.00126	0.0147	CbGeAlD
Caffeine—PRKDC—lymph node—Crohn's disease	0.00119	0.0139	CbGeAlD
Caffeine—PIK3CD—lymph node—Crohn's disease	0.00111	0.0131	CbGeAlD
Caffeine—ADORA2A—lymphoid tissue—Crohn's disease	0.00104	0.0122	CbGeAlD
Caffeine—PIK3CB—lymph node—Crohn's disease	0.000972	0.0114	CbGeAlD
Caffeine—PIK3CA—lymph node—Crohn's disease	0.000962	0.0113	CbGeAlD
Caffeine—CYP1A1—mouth—Crohn's disease	0.000901	0.0106	CbGeAlD
Caffeine—PDE4B—mammalian vulva—Crohn's disease	0.00075	0.0088	CbGeAlD
Caffeine—CYP1B1—smooth muscle tissue—Crohn's disease	0.000714	0.00838	CbGeAlD
Caffeine—CYP1B1—skin of body—Crohn's disease	0.000705	0.00827	CbGeAlD
Caffeine—PDE4B—lymphoid tissue—Crohn's disease	0.000666	0.00782	CbGeAlD
Caffeine—CYP1B1—lymphoid tissue—Crohn's disease	0.000571	0.0067	CbGeAlD
Caffeine—CYP1B1—digestive system—Crohn's disease	0.000564	0.00662	CbGeAlD
Caffeine—CYP1A1—epithelium—Crohn's disease	0.000524	0.00615	CbGeAlD
Caffeine—ADORA1—lymph node—Crohn's disease	0.000508	0.00596	CbGeAlD
Caffeine—CYP1A1—skin of body—Crohn's disease	0.000499	0.00585	CbGeAlD
Caffeine—CYP1A1—mammalian vulva—Crohn's disease	0.000455	0.00533	CbGeAlD
Caffeine—CYP1A2—digestive system—Crohn's disease	0.000404	0.00474	CbGeAlD
Caffeine—CYP1A1—digestive system—Crohn's disease	0.000399	0.00468	CbGeAlD
Caffeine—CYP3A5—digestive system—Crohn's disease	0.00039	0.00457	CbGeAlD
Caffeine—CYP2C9—digestive system—Crohn's disease	0.000384	0.0045	CbGeAlD
Caffeine—PDE4B—lymph node—Crohn's disease	0.000376	0.00441	CbGeAlD
Caffeine—CYP2E1—lymphoid tissue—Crohn's disease	0.000368	0.00432	CbGeAlD
Caffeine—CYP2E1—digestive system—Crohn's disease	0.000364	0.00427	CbGeAlD
Caffeine—CYP1B1—lymph node—Crohn's disease	0.000322	0.00378	CbGeAlD
Caffeine—CYP3A4—digestive system—Crohn's disease	0.000293	0.00343	CbGeAlD
Caffeine—CYP2D6—digestive system—Crohn's disease	0.000288	0.00338	CbGeAlD
Caffeine—ABCB1—epithelium—Crohn's disease	0.000272	0.00319	CbGeAlD
Caffeine—ABCB1—mammalian vulva—Crohn's disease	0.000236	0.00277	CbGeAlD
Caffeine—CYP1A1—lymph node—Crohn's disease	0.000228	0.00267	CbGeAlD
Caffeine—ABCB1—lymphoid tissue—Crohn's disease	0.00021	0.00246	CbGeAlD
Caffeine—ABCB1—digestive system—Crohn's disease	0.000207	0.00243	CbGeAlD
Caffeine—Sepsis—Mercaptopurine—Crohn's disease	0.000136	0.0574	CcSEcCtD
Caffeine—ABCB1—lymph node—Crohn's disease	0.000118	0.00139	CbGeAlD
Caffeine—Impaired healing—Prednisone—Crohn's disease	0.000104	0.0439	CcSEcCtD
Caffeine—Immune system disorder—Mercaptopurine—Crohn's disease	7.13e-05	0.03	CcSEcCtD
Caffeine—Deafness—Mesalazine—Crohn's disease	6.92e-05	0.0291	CcSEcCtD
Caffeine—Malnutrition—Mercaptopurine—Crohn's disease	6.87e-05	0.0289	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Mesalazine—Crohn's disease	6.19e-05	0.0261	CcSEcCtD
Caffeine—Blood creatinine increased—Mesalazine—Crohn's disease	5.8e-05	0.0244	CcSEcCtD
Caffeine—Dry skin—Mesalazine—Crohn's disease	5.68e-05	0.0239	CcSEcCtD
Caffeine—Gastritis—Mesalazine—Crohn's disease	5.48e-05	0.0231	CcSEcCtD
Caffeine—Skin disorder—Mercaptopurine—Crohn's disease	5.45e-05	0.0229	CcSEcCtD
Caffeine—Infestation—Azathioprine—Crohn's disease	5.24e-05	0.0221	CcSEcCtD
Caffeine—Infestation NOS—Azathioprine—Crohn's disease	5.24e-05	0.0221	CcSEcCtD
Caffeine—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	4.84e-05	0.0204	CcSEcCtD
Caffeine—Infestation NOS—Mesalazine—Crohn's disease	4.77e-05	0.0201	CcSEcCtD
Caffeine—Infestation—Mesalazine—Crohn's disease	4.77e-05	0.0201	CcSEcCtD
Caffeine—Haemoglobin—Azathioprine—Crohn's disease	4.73e-05	0.0199	CcSEcCtD
Caffeine—Haemorrhage—Azathioprine—Crohn's disease	4.7e-05	0.0198	CcSEcCtD
Caffeine—Renal failure—Mesalazine—Crohn's disease	4.69e-05	0.0197	CcSEcCtD
Caffeine—Haemoglobin—Mesalazine—Crohn's disease	4.31e-05	0.0181	CcSEcCtD
Caffeine—Haemorrhage—Mesalazine—Crohn's disease	4.29e-05	0.018	CcSEcCtD
Caffeine—Immune system disorder—Azathioprine—Crohn's disease	4.25e-05	0.0179	CcSEcCtD
Caffeine—Hypersensitivity—Mercaptopurine—Crohn's disease	4.13e-05	0.0174	CcSEcCtD
Caffeine—Pulmonary oedema—Prednisone—Crohn's disease	4.02e-05	0.0169	CcSEcCtD
Caffeine—Cardiac disorder—Mesalazine—Crohn's disease	3.98e-05	0.0167	CcSEcCtD
Caffeine—Sepsis—Prednisone—Crohn's disease	3.92e-05	0.0165	CcSEcCtD
Caffeine—Immune system disorder—Mesalazine—Crohn's disease	3.87e-05	0.0163	CcSEcCtD
Caffeine—Nervousness—Mesalazine—Crohn's disease	3.62e-05	0.0152	CcSEcCtD
Caffeine—Injury—Prednisone—Crohn's disease	3.57e-05	0.015	CcSEcCtD
Caffeine—Rash—Mercaptopurine—Crohn's disease	3.54e-05	0.0149	CcSEcCtD
Caffeine—Dermatitis—Mercaptopurine—Crohn's disease	3.53e-05	0.0149	CcSEcCtD
Caffeine—Infection—Azathioprine—Crohn's disease	3.32e-05	0.014	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Prednisone—Crohn's disease	3.28e-05	0.0138	CcSEcCtD
Caffeine—Skin disorder—Azathioprine—Crohn's disease	3.25e-05	0.0137	CcSEcCtD
Caffeine—Hypertension—Mesalazine—Crohn's disease	3.22e-05	0.0136	CcSEcCtD
Caffeine—Irritability—Prednisone—Crohn's disease	3.13e-05	0.0132	CcSEcCtD
Caffeine—Infection—Mesalazine—Crohn's disease	3.02e-05	0.0127	CcSEcCtD
Caffeine—Dry skin—Prednisone—Crohn's disease	3e-05	0.0126	CcSEcCtD
Caffeine—Nervous system disorder—Mesalazine—Crohn's disease	2.99e-05	0.0126	CcSEcCtD
Caffeine—Tachycardia—Mesalazine—Crohn's disease	2.97e-05	0.0125	CcSEcCtD
Caffeine—Skin disorder—Mesalazine—Crohn's disease	2.96e-05	0.0124	CcSEcCtD
Caffeine—Gastrointestinal disorder—Azathioprine—Crohn's disease	2.89e-05	0.0121	CcSEcCtD
Caffeine—Dyspnoea—Mesalazine—Crohn's disease	2.71e-05	0.0114	CcSEcCtD
Caffeine—Gastrointestinal disorder—Mesalazine—Crohn's disease	2.63e-05	0.0111	CcSEcCtD
Caffeine—Hyperglycaemia—Prednisone—Crohn's disease	2.56e-05	0.0108	CcSEcCtD
Caffeine—Hypersensitivity—Azathioprine—Crohn's disease	2.46e-05	0.0104	CcSEcCtD
Caffeine—Haemoglobin—Prednisone—Crohn's disease	2.28e-05	0.00959	CcSEcCtD
Caffeine—Haemorrhage—Prednisone—Crohn's disease	2.27e-05	0.00954	CcSEcCtD
Caffeine—Hypersensitivity—Mesalazine—Crohn's disease	2.24e-05	0.00944	CcSEcCtD
Caffeine—Rash—Azathioprine—Crohn's disease	2.11e-05	0.00887	CcSEcCtD
Caffeine—Dermatitis—Azathioprine—Crohn's disease	2.11e-05	0.00886	CcSEcCtD
Caffeine—Immune system disorder—Prednisone—Crohn's disease	2.05e-05	0.00862	CcSEcCtD
Caffeine—Malnutrition—Prednisone—Crohn's disease	1.97e-05	0.00831	CcSEcCtD
Caffeine—Rash—Mesalazine—Crohn's disease	1.92e-05	0.00808	CcSEcCtD
Caffeine—Dermatitis—Mesalazine—Crohn's disease	1.92e-05	0.00807	CcSEcCtD
Caffeine—PIK3CB—Signaling Pathways—SOCS1—Crohn's disease	1.91e-05	0.000113	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—TYK2—Crohn's disease	1.9e-05	0.000113	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—GCKR—Crohn's disease	1.9e-05	0.000113	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—FADS1—Crohn's disease	1.9e-05	0.000112	CbGpPWpGaD
Caffeine—ADORA2B—GPCR downstream signaling—JAK2—Crohn's disease	1.89e-05	0.000112	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—SOCS1—Crohn's disease	1.89e-05	0.000112	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—SMAD3—Crohn's disease	1.89e-05	0.000112	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CCR6—Crohn's disease	1.89e-05	0.000112	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—RIPK2—Crohn's disease	1.88e-05	0.000111	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—IL2RA—Crohn's disease	1.86e-05	0.00011	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—RIPK2—Crohn's disease	1.86e-05	0.00011	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	1.86e-05	0.00011	CbGpPWpGaD
Caffeine—PIK3CA—Disease—SMAD3—Crohn's disease	1.85e-05	0.000109	CbGpPWpGaD
Caffeine—ADORA2A—GPCR downstream signaling—IL2RA—Crohn's disease	1.85e-05	0.000109	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—IL3—Crohn's disease	1.83e-05	0.000108	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—JAK2—Crohn's disease	1.82e-05	0.000107	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by GPCR—TYK2—Crohn's disease	1.82e-05	0.000107	CbGpPWpGaD
Caffeine—PIK3CD—Signaling by GPCR—CXCL8—Crohn's disease	1.82e-05	0.000107	CbGpPWpGaD
Caffeine—Agitation—Prednisone—Crohn's disease	1.81e-05	0.00763	CcSEcCtD
Caffeine—PIK3CA—Signaling Pathways—UBE2D1—Crohn's disease	1.81e-05	0.000107	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—IL3—Crohn's disease	1.81e-05	0.000107	CbGpPWpGaD
Caffeine—ADORA2B—Signaling by GPCR—TYK2—Crohn's disease	1.8e-05	0.000106	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PLA2G4F—Crohn's disease	1.79e-05	0.000106	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—IFNG—Crohn's disease	1.78e-05	0.000105	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—GPX4—Crohn's disease	1.78e-05	0.000105	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—RASGRP1—Crohn's disease	1.77e-05	0.000105	CbGpPWpGaD
Caffeine—ABCB1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	1.77e-05	0.000104	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—MTMR3—Crohn's disease	1.76e-05	0.000104	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—MTMR3—Crohn's disease	1.76e-05	0.000104	CbGpPWpGaD
Caffeine—PIK3CD—Disease—TYK2—Crohn's disease	1.76e-05	0.000104	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—RIPK2—Crohn's disease	1.76e-05	0.000104	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—CRP—Crohn's disease	1.75e-05	0.000104	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—RASGRP1—Crohn's disease	1.75e-05	0.000104	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—IL2RA—Crohn's disease	1.75e-05	0.000103	CbGpPWpGaD
Caffeine—PIK3CB—GPCR downstream signaling—CXCL8—Crohn's disease	1.74e-05	0.000103	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	1.74e-05	0.000103	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by GPCR—JAK2—Crohn's disease	1.73e-05	0.000103	CbGpPWpGaD
Caffeine—ADORA2B—GPCR downstream signaling—CXCL8—Crohn's disease	1.73e-05	0.000102	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—CD4—Crohn's disease	1.72e-05	0.000102	CbGpPWpGaD
Caffeine—ADORA2B—Signaling by GPCR—JAK2—Crohn's disease	1.72e-05	0.000102	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—GCKR—Crohn's disease	1.72e-05	0.000101	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—IL3—Crohn's disease	1.71e-05	0.000101	CbGpPWpGaD
Caffeine—Convulsion—Prednisone—Crohn's disease	1.71e-05	0.0072	CcSEcCtD
Caffeine—ADORA2A—Signaling Pathways—RBX1—Crohn's disease	1.71e-05	0.000101	CbGpPWpGaD
Caffeine—Hypertension—Prednisone—Crohn's disease	1.7e-05	0.00717	CcSEcCtD
Caffeine—PIK3CA—Immune System—TLR4—Crohn's disease	1.68e-05	9.93e-05	CbGpPWpGaD
Caffeine—PIK3CD—Disease—JAK2—Crohn's disease	1.68e-05	9.92e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—IL2RA—Crohn's disease	1.68e-05	9.92e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—MTMR3—Crohn's disease	1.66e-05	9.84e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—PTGER4—Crohn's disease	1.66e-05	9.82e-05	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—TYK2—Crohn's disease	1.66e-05	9.82e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—RASGRP1—Crohn's disease	1.66e-05	9.8e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—SMAD3—Crohn's disease	1.65e-05	9.73e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—SMAD3—Crohn's disease	1.63e-05	9.64e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—ICAM1—Crohn's disease	1.61e-05	9.52e-05	CbGpPWpGaD
Caffeine—ADORA1—GPCR downstream signaling—JAK2—Crohn's disease	1.61e-05	9.51e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—SOCS1—Crohn's disease	1.61e-05	9.49e-05	CbGpPWpGaD
Caffeine—Infection—Prednisone—Crohn's disease	1.6e-05	0.00673	CcSEcCtD
Caffeine—PIK3CD—Innate Immune System—IL6—Crohn's disease	1.6e-05	9.46e-05	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—IL1B—Crohn's disease	1.59e-05	9.41e-05	CbGpPWpGaD
Caffeine—PIK3CD—Disease—CD4—Crohn's disease	1.59e-05	9.4e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by NGF—IL6—Crohn's disease	1.59e-05	9.4e-05	CbGpPWpGaD
Caffeine—PDE4B—GPCR downstream signaling—JAK2—Crohn's disease	1.59e-05	9.4e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—SOCS1—Crohn's disease	1.59e-05	9.38e-05	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—JAK2—Crohn's disease	1.58e-05	9.37e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by GPCR—CXCL8—Crohn's disease	1.58e-05	9.36e-05	CbGpPWpGaD
Caffeine—Nervous system disorder—Prednisone—Crohn's disease	1.58e-05	0.00665	CcSEcCtD
Caffeine—PIK3CD—Disease—PTGS2—Crohn's disease	1.58e-05	9.34e-05	CbGpPWpGaD
Caffeine—Tachycardia—Prednisone—Crohn's disease	1.57e-05	0.00662	CcSEcCtD
Caffeine—ADORA2B—Signaling by GPCR—CXCL8—Crohn's disease	1.57e-05	9.27e-05	CbGpPWpGaD
Caffeine—Skin disorder—Prednisone—Crohn's disease	1.56e-05	0.00658	CcSEcCtD
Caffeine—ABCB1—Metabolism—PLA2G4F—Crohn's disease	1.56e-05	9.24e-05	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—IFNG—Crohn's disease	1.55e-05	9.19e-05	CbGpPWpGaD
Caffeine—PIK3CB—Disease—TYK2—Crohn's disease	1.53e-05	9.06e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling by GPCR—TYK2—Crohn's disease	1.53e-05	9.05e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—MTMR3—Crohn's disease	1.52e-05	9.02e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—IL2RA—Crohn's disease	1.52e-05	9.01e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling by GPCR—TYK2—Crohn's disease	1.51e-05	8.95e-05	CbGpPWpGaD
Caffeine—PIK3CD—Metabolism—ALB—Crohn's disease	1.51e-05	8.94e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—IL2RA—Crohn's disease	1.51e-05	8.93e-05	CbGpPWpGaD
Caffeine—PIK3CA—GPCR downstream signaling—JAK2—Crohn's disease	1.5e-05	8.9e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—SOCS1—Crohn's disease	1.5e-05	8.88e-05	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—CD4—Crohn's disease	1.5e-05	8.88e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—UBE2D1—Crohn's disease	1.5e-05	8.85e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PLA2G4F—Crohn's disease	1.47e-05	8.71e-05	CbGpPWpGaD
Caffeine—ADORA1—GPCR downstream signaling—CXCL8—Crohn's disease	1.47e-05	8.68e-05	CbGpPWpGaD
Caffeine—PIK3CB—Disease—JAK2—Crohn's disease	1.46e-05	8.65e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling by GPCR—JAK2—Crohn's disease	1.46e-05	8.64e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PLA2G4F—Crohn's disease	1.46e-05	8.63e-05	CbGpPWpGaD
Caffeine—PRKDC—Immune System—IL6—Crohn's disease	1.46e-05	8.61e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—RIPK2—Crohn's disease	1.45e-05	8.58e-05	CbGpPWpGaD
Caffeine—PDE4B—GPCR downstream signaling—CXCL8—Crohn's disease	1.45e-05	8.58e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling by GPCR—JAK2—Crohn's disease	1.44e-05	8.53e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by GPCR—TYK2—Crohn's disease	1.43e-05	8.47e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—IL3—Crohn's disease	1.41e-05	8.37e-05	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	1.4e-05	8.29e-05	CbGpPWpGaD
Caffeine—PIK3CB—Innate Immune System—IL6—Crohn's disease	1.39e-05	8.24e-05	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—IL1B—Crohn's disease	1.39e-05	8.2e-05	CbGpPWpGaD
Caffeine—PIK3CB—Disease—CD4—Crohn's disease	1.39e-05	8.2e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—SMAD3—Crohn's disease	1.39e-05	8.2e-05	CbGpPWpGaD
Caffeine—PIK3CB—Disease—PTGS2—Crohn's disease	1.38e-05	8.14e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—FADS1—Crohn's disease	1.37e-05	8.13e-05	CbGpPWpGaD
Caffeine—PIK3CA—GPCR downstream signaling—CXCL8—Crohn's disease	1.37e-05	8.12e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—FADS1—Crohn's disease	1.37e-05	8.11e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—SMAD3—Crohn's disease	1.37e-05	8.1e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—RASGRP1—Crohn's disease	1.37e-05	8.09e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by GPCR—JAK2—Crohn's disease	1.37e-05	8.08e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.36e-05	8.04e-05	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—STAT3—Crohn's disease	1.33e-05	7.89e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling by GPCR—CXCL8—Crohn's disease	1.33e-05	7.88e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—MTMR3—Crohn's disease	1.33e-05	7.86e-05	CbGpPWpGaD
Caffeine—PIK3CD—Metabolism—PTGS2—Crohn's disease	1.32e-05	7.82e-05	CbGpPWpGaD
Caffeine—PIK3CB—Metabolism—ALB—Crohn's disease	1.32e-05	7.79e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling by GPCR—CXCL8—Crohn's disease	1.32e-05	7.79e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—TYK2—Crohn's disease	1.31e-05	7.74e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—SMAD3—Crohn's disease	1.3e-05	7.67e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—FADS1—Crohn's disease	1.3e-05	7.66e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—GPX4—Crohn's disease	1.29e-05	7.61e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—GPX4—Crohn's disease	1.28e-05	7.59e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—IL2RA—Crohn's disease	1.28e-05	7.59e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—IL2RA—Crohn's disease	1.27e-05	7.5e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—MTMR3—Crohn's disease	1.25e-05	7.4e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—JAK2—Crohn's disease	1.25e-05	7.38e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PLA2G4F—Crohn's disease	1.25e-05	7.38e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by GPCR—CXCL8—Crohn's disease	1.25e-05	7.37e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—GCKR—Crohn's disease	1.24e-05	7.35e-05	CbGpPWpGaD
Caffeine—ADORA2A—GPCR downstream signaling—JAK2—Crohn's disease	1.24e-05	7.34e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—MTMR3—Crohn's disease	1.24e-05	7.34e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—GCKR—Crohn's disease	1.24e-05	7.34e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—SOCS1—Crohn's disease	1.24e-05	7.33e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—TYK2—Crohn's disease	1.23e-05	7.28e-05	CbGpPWpGaD
Caffeine—PIK3CD—Disease—STAT3—Crohn's disease	1.23e-05	7.28e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—IFNG—Crohn's disease	1.23e-05	7.24e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—GPX4—Crohn's disease	1.21e-05	7.18e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—TYK2—Crohn's disease	1.21e-05	7.14e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—IL2RA—Crohn's disease	1.2e-05	7.1e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.19e-05	7.04e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—FADS1—Crohn's disease	1.19e-05	7.03e-05	CbGpPWpGaD
Caffeine—Hypersensitivity—Prednisone—Crohn's disease	1.19e-05	0.00499	CcSEcCtD
Caffeine—PIK3CA—Immune System—CD4—Crohn's disease	1.18e-05	7e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—TYK2—Crohn's disease	1.18e-05	6.99e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—JAK2—Crohn's disease	1.17e-05	6.95e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—GCKR—Crohn's disease	1.17e-05	6.93e-05	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—STAT3—Crohn's disease	1.16e-05	6.87e-05	CbGpPWpGaD
Caffeine—PIK3CB—Metabolism—PTGS2—Crohn's disease	1.15e-05	6.81e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—JAK2—Crohn's disease	1.15e-05	6.81e-05	CbGpPWpGaD
Caffeine—ADORA2A—GPCR downstream signaling—CXCL8—Crohn's disease	1.13e-05	6.7e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—JAK2—Crohn's disease	1.13e-05	6.67e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—GPX4—Crohn's disease	1.11e-05	6.58e-05	CbGpPWpGaD
Caffeine—PIK3CA—Innate Immune System—IL6—Crohn's disease	1.1e-05	6.5e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—IL1B—Crohn's disease	1.09e-05	6.46e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—CD4—Crohn's disease	1.09e-05	6.46e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—PTGS2—Crohn's disease	1.08e-05	6.41e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—GCKR—Crohn's disease	1.07e-05	6.35e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—TYK2—Crohn's disease	1.07e-05	6.35e-05	CbGpPWpGaD
Caffeine—PIK3CB—Disease—STAT3—Crohn's disease	1.07e-05	6.35e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—CXCL8—Crohn's disease	1.07e-05	6.34e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—SMAD3—Crohn's disease	1.07e-05	6.33e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—TYK2—Crohn's disease	1.06e-05	6.29e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—MTMR3—Crohn's disease	1.06e-05	6.27e-05	CbGpPWpGaD
Caffeine—PIK3CA—Metabolism—ALB—Crohn's disease	1.04e-05	6.14e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—FADS1—Crohn's disease	1.04e-05	6.12e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—CXCL8—Crohn's disease	1.03e-05	6.09e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—JAK2—Crohn's disease	1.02e-05	6.06e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling by GPCR—IL6—Crohn's disease	1.02e-05	6.03e-05	CbGpPWpGaD
Caffeine—Rash—Prednisone—Crohn's disease	1.02e-05	0.00427	CcSEcCtD
Caffeine—Dermatitis—Prednisone—Crohn's disease	1.01e-05	0.00427	CcSEcCtD
Caffeine—ADORA2B—Signaling Pathways—JAK2—Crohn's disease	1.01e-05	6e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—IL2RA—Crohn's disease	9.91e-06	5.86e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—FADS1—Crohn's disease	9.75e-06	5.77e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—GPX4—Crohn's disease	9.69e-06	5.73e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—FADS1—Crohn's disease	9.67e-06	5.72e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	9.63e-06	5.69e-05	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	9.46e-06	5.59e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—GCKR—Crohn's disease	9.36e-06	5.54e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—CXCL8—Crohn's disease	9.35e-06	5.53e-05	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—IL6—Crohn's disease	9.32e-06	5.51e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—CXCL8—Crohn's disease	9.26e-06	5.48e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—STAT3—Crohn's disease	9.16e-06	5.42e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—GPX4—Crohn's disease	9.13e-06	5.4e-05	CbGpPWpGaD
Caffeine—PIK3CA—Metabolism—PTGS2—Crohn's disease	9.08e-06	5.37e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—GPX4—Crohn's disease	9.05e-06	5.35e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—TYK2—Crohn's disease	9.04e-06	5.35e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—TYK2—Crohn's disease	8.94e-06	5.28e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by GPCR—IL6—Crohn's disease	8.89e-06	5.26e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—GCKR—Crohn's disease	8.82e-06	5.22e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling by GPCR—IL6—Crohn's disease	8.81e-06	5.21e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—GCKR—Crohn's disease	8.74e-06	5.17e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—JAK2—Crohn's disease	8.63e-06	5.1e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—STAT3—Crohn's disease	8.62e-06	5.1e-05	CbGpPWpGaD
Caffeine—PIK3CD—Disease—IL6—Crohn's disease	8.6e-06	5.09e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—JAK2—Crohn's disease	8.53e-06	5.04e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—TYK2—Crohn's disease	8.46e-06	5e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—STAT3—Crohn's disease	8.46e-06	5e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	8.38e-06	4.95e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—FADS1—Crohn's disease	8.26e-06	4.89e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—MTMR3—Crohn's disease	8.19e-06	4.84e-05	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—IL6—Crohn's disease	8.12e-06	4.8e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—JAK2—Crohn's disease	8.07e-06	4.77e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—CXCL8—Crohn's disease	7.87e-06	4.66e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—CXCL8—Crohn's disease	7.78e-06	4.6e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—GPX4—Crohn's disease	7.74e-06	4.58e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	7.68e-06	4.54e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—STAT3—Crohn's disease	7.52e-06	4.44e-05	CbGpPWpGaD
Caffeine—PIK3CB—Disease—IL6—Crohn's disease	7.5e-06	4.43e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling by GPCR—IL6—Crohn's disease	7.49e-06	4.43e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—GCKR—Crohn's disease	7.47e-06	4.42e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—STAT3—Crohn's disease	7.45e-06	4.4e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling by GPCR—IL6—Crohn's disease	7.4e-06	4.37e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—CXCL8—Crohn's disease	7.37e-06	4.36e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	7.33e-06	4.33e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by GPCR—IL6—Crohn's disease	7e-06	4.14e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—TYK2—Crohn's disease	6.98e-06	4.13e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	6.72e-06	3.97e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—JAK2—Crohn's disease	6.66e-06	3.94e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—IL6—Crohn's disease	6.4e-06	3.78e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—FADS1—Crohn's disease	6.38e-06	3.77e-05	CbGpPWpGaD
Caffeine—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	6.36e-06	3.76e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—STAT3—Crohn's disease	6.33e-06	3.74e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—STAT3—Crohn's disease	6.26e-06	3.7e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	6.25e-06	3.7e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CXCL8—Crohn's disease	6.08e-06	3.59e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—ALB—Crohn's disease	6.06e-06	3.58e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—IL6—Crohn's disease	6.02e-06	3.56e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—GPX4—Crohn's disease	5.97e-06	3.53e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—STAT3—Crohn's disease	5.92e-06	3.5e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—IL6—Crohn's disease	5.91e-06	3.49e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—IL6—Crohn's disease	5.78e-06	3.42e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—GCKR—Crohn's disease	5.77e-06	3.41e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	5.47e-06	3.23e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—ALB—Crohn's disease	5.46e-06	3.23e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	5.34e-06	3.16e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—PTGS2—Crohn's disease	5.3e-06	3.13e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—IL6—Crohn's disease	5.25e-06	3.1e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—IL6—Crohn's disease	5.2e-06	3.08e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—STAT3—Crohn's disease	4.89e-06	2.89e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PTGS2—Crohn's disease	4.78e-06	2.83e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	4.67e-06	2.76e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—IL6—Crohn's disease	4.42e-06	2.62e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—IL6—Crohn's disease	4.37e-06	2.58e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—IL6—Crohn's disease	4.14e-06	2.45e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—ALB—Crohn's disease	3.96e-06	2.34e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—ALB—Crohn's disease	3.95e-06	2.33e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—ALB—Crohn's disease	3.73e-06	2.21e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PTGS2—Crohn's disease	3.46e-06	2.05e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PTGS2—Crohn's disease	3.45e-06	2.04e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—ALB—Crohn's disease	3.42e-06	2.02e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—IL6—Crohn's disease	3.42e-06	2.02e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PTGS2—Crohn's disease	3.26e-06	1.93e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PTGS2—Crohn's disease	2.99e-06	1.77e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—ALB—Crohn's disease	2.98e-06	1.76e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—ALB—Crohn's disease	2.81e-06	1.66e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—ALB—Crohn's disease	2.78e-06	1.65e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PTGS2—Crohn's disease	2.61e-06	1.54e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PTGS2—Crohn's disease	2.46e-06	1.45e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PTGS2—Crohn's disease	2.43e-06	1.44e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—ALB—Crohn's disease	2.38e-06	1.41e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PTGS2—Crohn's disease	2.08e-06	1.23e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ALB—Crohn's disease	1.84e-06	1.09e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PTGS2—Crohn's disease	1.61e-06	9.5e-06	CbGpPWpGaD
